Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Carlsmed, Inc. (CARL : NSDQ)

• Company Description    Carlsmed Inc. is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions. Carlsmed Inc. is based in CARLSBAD, Calif. Number of Employees: 100

• Price / Volume Information    Yesterday's Closing Price: $14.79 Daily Weekly Monthly 20 Day Moving Average: 85,938 shares Shares Outstanding: 26.58 (millions) Market Capitalization: $393.13 (millions) Beta: 52 Week High: $15.20 52 Week Low: $11.81 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 6.02% 4.16% 12 Week % % Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1800 ASTON AVENUE SUITE 100 - CARLSBAD,CA 92008 USA ph: 760-766-1923 fax: - None http://www.carlsmed.com

• General Corporate Information    Officers Michael (Mike) Cordonnier - Chief Executive Officer; President; Chairman Leonard (Leo) Greenstein - Chief Financial Officer; Treasurer Niall Casey - Director Philip (Phil) Young - Director Kevin Sidow - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 14280C105 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/27/25 Share - Related Items Shares Outstanding: 26.58 Most Recent Split Date: (:1) Beta: Market Capitalization: $393.13 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.41 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.40 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 42.64% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/27/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - - Quick Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - - Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - - 12/31/24 - - Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©